Tag Archives: Times

2nd time’s the charm? Novo Nordisk reups bid for high-dose Ozempic after March FDA snub

Novo Nordisk is back for round two with a new Ozempic dosing regimen. The diabetes specialist resubmitted to the FDA on Friday after a March snub, renewing its bid to compete with Eli Lilly’s already approved higher dose. Novo’s resubmission aims to nab an approval for a once-weekly, 2-mg dose for Ozempic, a GLP-1 drug already approved for weekly dosing at… Read More »

Staying positive during difficult times

To say we’re living through challenging times sounds like both a cliché and an understatement. In recent months, news about the pandemic, economic woes, and bitter political debates have triggered tremendous anxiety and sadness for many Americans. But when people look back on their lives, it is usually the most difficult challenges that gave them… Read More »